Kim Ki-Hun, Kim Sang-Hoon, Cho Hwui-Dong
Division of Liver Transplantation and Hepatobiliary Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Division of Liver Transplantation and Hepatobiliary Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Transplant Rev (Orlando). 2023 Jan;37(1):100747. doi: 10.1016/j.trre.2023.100747. Epub 2023 Feb 3.
A standard graft-to-recipient weight ratio (GRWR) ≥0.8% is widely accepted in living-donor liver transplantation (LDLT); however, the potential donor pool is expanded to patients adopting small-for-size graft (SFSGs) with GRWR <0.8%. This study aimed to investigate the effect of SFSG on short- and long-term outcomes following LDLT.
Electronic databases were searched from January 1995 to January 2022 for studies comparing short- or long-term outcomes between patients with SFSG (GRWR <0.8%, SFSG group) and sufficient volume graft (GRWR ≥0.8%, non-SFSG group). The primary outcomes were one-, three-, and five-year overall survival (OS) and graft survival (GS), while the secondary outcome was postoperative complications.
Twenty-four studies comprising 7996 patients were included. In terms of OS, SFSG group had poor three-year OS (HR: 1.48, 95% CI [1.01, 2.15], p = 0.04), but there were no significant differences between two groups in one-year OS (HR: 1.50, 95% CI [0.98, 2.29], p = 0.06) and five-year OS (HR: 1.40, 95% CI [0.95, 2.08], p = 0.02). In GS, there were no significant differences in one-year (HR 1.31, 95% CI [1.00, 1.72], p = 0.05), three-year (HR 1.33, 95% CI [0.97, 1.82], p = 0.07), and five-year GS (HR 1.17, 95% CI [0.95, 1.44], p = 0.13). The SFSG group had comparable postoperative complications, except for a high incidence of vascular complications and small-for-size syndromes.
Expanding the potential donor pool in LDLT to SFSG with GRWR <0.8% can be acceptable in terms of comparable long-term OS and GS, despite the risk for vascular complications and small-for-size syndrome.
在活体肝移植(LDLT)中,标准的移植物与受者体重比(GRWR)≥0.8%已被广泛接受;然而,潜在供体库已扩大到采用移植物过小(SFSG)且GRWR<0.8%的患者。本研究旨在调查SFSG对LDLT术后短期和长期结局的影响。
检索1995年1月至2022年1月的电子数据库,以查找比较SFSG患者(GRWR<0.8%,SFSG组)和移植物体积足够的患者(GRWR≥0.8%,非SFSG组)短期或长期结局的研究。主要结局为1年、3年和5年总生存率(OS)和移植物生存率(GS),次要结局为术后并发症。
纳入了24项研究,共7996例患者。在OS方面,SFSG组3年OS较差(HR:1.48,95%CI[1.01,2.15],p = 0.04),但两组在1年OS(HR:1.50,95%CI[0.98,2.29],p = 0.06)和5年OS(HR:1.40,95%CI[0.95,2.08],p = 0.02)方面无显著差异。在GS方面,1年(HR 1.31,95%CI[1.00,1.72],p = 0.05)、3年(HR 1.33,95%CI[0.97,1.82],p = 0.07)和5年GS(HR 1.17,95%CI[0.95,1.44],p = 0.13)无显著差异。SFSG组术后并发症相当,但血管并发症和移植物过小综合征的发生率较高。
尽管存在血管并发症和移植物过小综合征的风险,但将LDLT的潜在供体库扩大到GRWR<0.8%的SFSG在长期OS和GS相当的情况下是可以接受的。